This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsFlavonoids in Medical Research · Cancer, Lipids, and Metabolism · Protease and Inhibitor Mechanisms
Following the publication of this article [1] concerns were raised with results presented in Figs 1-3. Specifically:
The corresponding author stated that the panels included in [1] represent the original experimental outputs as obtained at the time of the study, with only uniform, global adjustments to brightness and contrast applied. They also stated that the underlying data for the above figures are no longer available. The corresponding author provided original plate images for Fig 2 which did not resolve the concerns.
In light of the above concerns which call into question the reliability and integrity of the published results, the PLOS One Editors retract this article.
DDA and RVI did not agree with the retraction. MF, AM, and RB did not agree with the retraction and stand by the article’s findings. JL, AV, MPG, PMC, BW, MR, DSB and LGG either did not respond directly or could not be reached.
The left and right Mitostatin and β-actin panels of Fig 1B report material similar to that published in Fig 6A in [2], published in 2008 by Springer Nature. The left and right Mitostatin and β-actin panels of Fig 1B are not offered under a CC BY license and are therefore excluded from this article’s [1] license.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Fassan M, D’Arca D, Letko J, Vecchione A, Gardiman MP, Mc Cue P, et al. RETRACTED: Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. P Lo S One. 2011;6(5):e 19771. doi: 10.1371/journal.pone.0019771 21573075 PMC 3089640 · doi ↗ · pubmed ↗
- 2Vecchione A, Fassan M, Anesti V, Morrione A, Goldoni S, Baldassarre G, et al. MITOSTATIN, a putative tumor suppressor on chromosome 12q 24.1, is downregulated in human bladder and breast cancer. Oncogene. 2009;28(2):257–69. doi: 10.1038/onc.2008.381 18931701 PMC 2628456 · doi ↗ · pubmed ↗
